Inquiry Basket
Loading ......
Tetrodotoxin (TTX) stands as the deadliest natural neurotoxin because it exists naturally in pufferfish and particular marine species. The toxic effects of TTX become deadly when people ingest even small amounts of the substance so fast and accurate detection methods must be available for food safety and public health protection. Mass spectrometry methods enable precise TTX detection but their operation requires specialized equipment and long testing periods which limits their use for standard screening tests. Competitive ELISA stands out as an excellent laboratory and field-based choice because it delivers high sensitivity through its fast results and large-scale testing capabilities.
The small molecule hapten TTX exists as a single compound which fails to initiate immune responses independently. Scientists must link TTX to carrier proteins which consist of bovine serum albumin (BSA) for immunization and ovalbumin (OVA) for assay coating to generate specific antibodies. The immunization process for mice needs regular scheduled injections with additional booster shots to achieve the highest antibody production. The process of TTX handling takes place only in BSL-2 laboratories where staff members wear protective equipment to stop airborne contamination.
Figure 1. Schematic diagram of the mechanism of TTX detection method.(Source: Lin C, et al.; 2024)
The hybridoma creation process using splenocytes and myeloma cells produces cell lines which generate continuous monoclonal antibody (mAb) production against TTX. The purification methods of affinity chromatography and caprylic acid precipitation help achieve high specificity and activity while reducing the risk of cross-reactivity. The developed antibodies serve as initial components to construct TTX detection systems which produce exact and reliable results.
Competitive ELISA leverages these antibodies for quantification. In this format, TTX in the sample competes with immobilized TTX on a plate for antibody binding. The resulting signal inversely reflects toxin concentration. Modern ELISAs can detect TTX as low as 0.05 ng/mL, delivering results in 45–90 minutes with high precision.
The process of preparing samples stands as a fundamental requirement for achieving accurate results. The preparation of tissues involves three steps which include acid dilution followed by heat treatment or ultrasonic processing and solid-phase extraction (SPE) for substance removal. Scientists create dependable quantification methods through matrix-matched calibration curves because these curves enable analysis of various sample types.
Scientists developed TTX detection systems through nanomaterials combined with microfluidics technology which produces fast results in small devices. The AuNP lateral flow assay produces visual results after a 10-15 minute process and smartphone applications allow users to measure results quantitatively. Users must buy separate readers to operate magnetic and electrochemical platforms which detect picogram levels. The competitive immunoassay based on microfluidics operates through TTX-coated channels which combine labeled antibodies to detect substances at concentrations below 5 ng/mL during a 45-minute period. The new technologies enable fast field-based testing which connects laboratory-based precision to real-world applications.
The detection of TTX needs both sensitive antibodies and strong assays together with proper validation methods and safe laboratory procedures. The production of reliable results in immunoassays depends on three critical factors which include precise calibration and stable recovery of spiked samples and minimal cross-reactivity with similar toxins. Laboratories achieve test accuracy through standardized procedures which involve using certified TTX reference materials and creating calibration curves based on sample types.
Safety is equally critical. The toxic select agent TTX needs BSL-2 laboratory work with protective equipment and restricted entry and proper waste disposal protocols. The process of neutralizing spills involves using sodium hypochlorite disinfectant followed by autoclaving all contaminated items to eliminate exposure threats. Researchers can execute TTX immunoassays with assurance through validated methods and enhanced safety protocols which protect people and environmental health.
Scientists continue to develop innovative techniques which enhance antibody precision and create basic detection systems and ELISA and nanomaterial-based assays demonstrate successful applications. Phage display technology enables the production of recombinant antibodies which generate scFvs that demonstrate enhanced specificity and reproducibility compared to traditional monoclonal antibodies and minimize batch-to-batch variability. The combination of assays with portable reading devices such as lateral flow readers and digital scanners enables quantitative field-based measurements that achieve laboratory-grade precision. The current advancements in TTX detection technology work toward creating faster and more reliable tests which can be used in real-world applications.
The development of TTX immunoassays shows how safety standards lead to innovative solutions which stay functional through antibody production and ELISA and nanomaterial and microfluidic assay development. The current detection methods provide fast and sensitive toxin identification at large scales which protects human health during various testing requirements. The creation of recombinant antibodies and portable platforms and smartphone integration will lead to the development of fast and secure TTX monitoring systems which will provide toxin detection capabilities to all users.
The detection process of TTX requires immunological methods because mass spectrometry and chromatography need expensive equipment and complicated procedures. The competitive ELISA method provides fast laboratory and field-based TTX detection at extremely low concentrations because it shows high sensitivity. The method provides fast results at affordable costs which makes it suitable for food safety inspections and first medical screenings.
The immune system needs assistance to detect TTX because this toxin molecule weighs only 319 Da. Scientists use BSA proteins to make TTX detectable by the immune system which produces specific antibodies against these proteins. Scientists use hybridoma technology to create cells which produce continuous monoclonal antibody production for creating specific and reusable antibody batches.
The ELISA test enables TTX molecules in samples to compete with TTX molecules that are already attached to the plate for available antibody binding locations. The amount of TTX present in samples determines how much antibody will bind to immobilized TTX which produces a lower detection signal. The detection method uses a standard curve to transform signal output into TTX concentration measurements which provides quantitative results with high sensitivity and measurement precision.
Reference
| Target | Cat. No. | Product Name | Host | Application | |
| TTX | DPAB-DC4815 | Anti-Tetrodotoxin polyclonal antibody | Rabbit | ELISA | Inquiry |
| TTX | CABT-L3089 | Mouse Anti-Tetrodotoxin monoclonal antibody, clone TTX | Mouse | ELISA, LFIA | Inquiry |
| Target | Cat. No. | Product Name | Type | Conjugate | Application | |
| TTX | DAG3416 | Tetrodotoxin [BSA] | TTX | BSA | ELISA, LFIA | Inquiry |
| TTX | DAG034S | Tetrodotoxin [HRP] | N/A | HRP | ELISA, LF | Inquiry |
| TTX | DAG035S | Tetrodotoxin [BSA] | TTX | BSA | ELISA, LFIA | Inquiry |
| TTX | DAG3416O | Tetrodotoxin [OVA] | TTX | OVA | ELISA, LFIA | Inquiry |
| TTX | DAG-WT1763 | Tetrodotoxin (>98%) | N/A | N/A | ELISA | Inquiry |
| TTX | DAG035K | Tetrodotoxin [KLH] | N/A | KLH | ELISA, LF | Inquiry |
| Target | Cat. No. | Product Name | Size | Species Reactivity | Application | |
| TTX | DEIANJ48NS | Tetrodotoxin ELISA Kit | 96T | N/A | Quantitative | Inquiry |
| TTX | DEIANJ48 | Tetrodotoxin ELISA Kit | 96T | N/A | Quantitative | Inquiry |
Loading ......
